• Lipidated Nanophotosensitizers Disable Tumor Extracellular V

  2026-05-13

  The referenced study introduces a lipidated nanophotosensitizer that traces and disables tumor extracellular vesicles (TEVs) to concurrently inhibit tumor growth and metastasis. This dual-function approach addresses the persistent challenge of selectively targeting TEV-mediated communication in cancer, offering a new paradigm for antimetastatic therapy.

• Microraft Array Screening Reveals Heterogeneity in Human Gas

  2026-05-13

  This study introduces an automated microraft array platform for high-throughput screening and sorting of single gastruloids derived from human pluripotent stem cells, enabling quantitative analysis of chromosomal mosaicism during early embryogenesis. By integrating phenotypic imaging and transcriptomics, the research advances understanding of self-organization and mechanisms underlying aneuploidy depletion, with implications for improving embryo assessment in reproductive medicine.

• Glutamine-STAT3-PD-L1 Axis in Pancreatic Cancer Regulation

  2026-05-12

  The referenced study uncovers how glutamine availability regulates PD-L1 expression through STAT3 signaling in pancreatic cancer. This mechanism links metabolic homeostasis to immune checkpoint modulation, suggesting new avenues for targeted therapies and metabolic-immune interplay research.

• Technical Guide: Hoechst 33342/PI Double Staining Kit (K2237

  2026-05-12

  The Hoechst 33342/PI Double Staining Kit provides a direct, dual-fluorescence method for distinguishing viable, apoptotic, and necrotic cells in basic research. It is best suited for fluorescence microscopy workflows requiring assessment of chromatin condensation and membrane integrity. This kit is not intended for diagnostic or clinical use.

• Multi-Omics Dissects ARID1A-Driven Resistance in Melanoma

  2026-05-11

  This study leverages integrative multi-omics to unravel the mechanisms by which loss of ARID1A drives resistance to BRAF/MAPK inhibitors in melanoma. The findings identify key signaling nodes and immune evasion pathways, offering new insights for overcoming acquired resistance and improving targeted therapeutic strategies.

• D2-like Dopamine Receptor Activation Restores Network Functi

  2026-05-11

  This study demonstrates that activation of D2-like dopamine receptors reverses impaired hippocampal γ oscillations and cognitive deficits in a mouse model of infantile neuronal ceroid lipofuscinosis (INCL) caused by PPT1 deficiency. The findings identify specific dopamine receptor subunits as potential therapeutic targets for neurodegenerative lysosomal storage disorders.

• Bleomycin Sulfate (SKU A8331): Reliable Solutions for DNA Da

  2026-05-10

  This article delivers scenario-driven, evidence-based guidance for deploying Bleomycin Sulfate (SKU A8331) in cell viability, chemotherapy-induced DNA damage, and pulmonary fibrosis research. Through real-world Q&A, it demonstrates how researchers can leverage validated protocols and literature-backed selectivity to overcome common laboratory challenges and generate reproducible results.

• BIBR 1532 Telomerase Inhibitor: Workflows and Troubleshootin

  2026-05-09

  BIBR 1532 is a precision tool for dissecting telomerase-dependent cancer mechanisms, enabling robust telomerase activity assays and apoptosis induction studies. This guide translates bench research into actionable protocols, highlights troubleshooting strategies, and connects recent synergistic telomere attrition findings to practical lab workflows.

• PF-562271 HCl: Transforming FAK/Pyk2 Inhibition in Oncology

  2026-05-08

  PF-562271 HCl, a highly selective FAK/Pyk2 inhibitor from APExBIO, is redefining translational cancer research by enabling precise modulation of focal adhesion kinase signaling. This article provides mechanistic insight, strategic experimental guidance, and a forward-looking perspective on leveraging PF-562271 HCl to overcome tumor growth, metastasis, and resistance. Integrating recent immuno-oncology findings and advanced workflow recommendations, it empowers researchers to move beyond conventional assay endpoints toward clinically relevant tumor models.

• Sodium Overload Impairs Mitochondrial Metabolism via TRPM4-D

  2026-05-08

  Qiao et al. reveal how sodium influx through TRPM4 disrupts mitochondrial metabolism, suppressing energy production and triggering necrotic cell death (NECSO). Their mechanistic insights clarify the role of ion imbalances in cell fate and highlight tools for mitochondrial function analysis.

• Biotin-16-UTP: Catalyzing lncRNA-Protein Insights in HCC

  2026-05-07

  Explore how Biotin-16-UTP empowers mechanistic and translational advances in hepatocellular carcinoma (HCC) research. This thought-leadership article bridges the latest findings on lncRNA-protein interactions, especially LINC02870’s role in HCC, with best practices in biotin-labeled RNA synthesis. We highlight APExBIO’s Biotin-16-UTP as a pivotal tool for next-generation RNA-protein interaction studies, referencing both landmark research and practical workflow guidance.

• Tigecycline in Antimicrobial Resistance: Mechanisms, Models

  2026-05-07

  Explore Tigecycline’s advanced mechanism as a glycylcycline antibiotic and its application in multidrug-resistant infection models. This article uniquely connects molecular pharmacology to practical assay design, with new perspectives on resistance gene dynamics.

• Dopamine Regulates Osteoclast Differentiation via cAMP/PKA/C

  2026-05-06

  Wang et al. reveal that dopamine suppresses osteoclast differentiation by inhibiting the cAMP/PKA/CREB pathway. Their findings clarify neuroendocrine regulation of bone remodeling and highlight new molecular targets for bone disease research.

• Trypsin in Translational Research: Mechanistic Precision & I

  2026-05-06

  This thought-leadership article explores the nuanced role of Trypsin, a serine protease, in advancing translational research. We synthesize mechanistic insights, experimental best practices, and the latest evidence connecting proteolytic activity to genomic stability and cellular fate decisions. Researchers will find strategic guidance for protocol optimization, competitive differentiation, and clinical translation, as well as a critical appraisal of APExBIO's Trypsin (SKU: BA5744) as a precision tool, with actionable takeaways for experimental design.

• NF90 Deficiency Mitigates Diabetic Vascular Calcification vi

  2026-05-05

  This study uncovers how smooth muscle NF90 promotes diabetic atherosclerotic calcification through FBXW7-mediated AGER1 degradation, exacerbating AGE accumulation. Targeted NF90 deficiency in vascular smooth muscle cells attenuates vascular calcification, offering mechanistic insight and a potential therapeutic target for diabetic cardiovascular complications.

16006 records 1/1068 page Next 12345 下5页 Last page